Eris Lifesciences share news, announcements and annual reports
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,163.60.
30 Oct: open ₹1,163.00, high ₹1,174.70, low ₹1,148.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,044 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.67
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.87
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.62%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 31,21340.7% delivered
Eris Lifesciences board meetings
90 filed, newest first. Page 2 of 2.
Jul 2021
21 Jul · Board meeting
May 2021
13 May · Board meeting
Jan 2021
28 Jan · Board meeting
21 Jan · Board meeting
Nov 2020
3 Nov · Board meeting
Oct 2020
27 Oct · Board meeting
Aug 2020
5 Aug · Board meeting
Jul 2020
Jun 2020
26 Jun · Board meeting
23 Jun · Board meeting
2 Jun · Board meeting
May 2020
30 May · Board meeting
Mar 2020
5 Mar · Board meeting
Feb 2020
14 Feb · Board meeting
7 Feb · Board meeting
Nov 2019
7 Nov · Board meeting
Oct 2019
24 Oct · Board meeting
Jul 2019
29 Jul · Board meeting
27 Jul · Board meeting
20 Jul · Board meeting
3 Jul · Board meeting
Jun 2019
24 Jun · Board meeting
May 2019
21 May · Board meeting
14 May · Board meeting
Jan 2019
29 Jan · Board meeting
21 Jan · Board meeting
Nov 2018
3 Nov · Board meeting
3 Nov · Board meeting
3 Nov · Board meeting
Oct 2018
25 Oct · Board meeting
Aug 2018
9 Aug · Board meeting
May 2018
25 May · Board meeting
Feb 2018
Nov 2017
Aug 2017
17 Aug · Board meeting